Oncognse des tumeurs respiratoires et urognitales - Service d ...

GETU
92. Salomon, L., Anastasiadis, A. G., Levrel, O., Katz, R., Saint, F., de la Taille, A., Cicco, A., Vordos, D.,
Hoznek, A., Chopin, D., and Abbou, C. C. Location of positive surgical margins after retropubic, perineal,
and laparoscopic radical prostatectomy for organ-confined prostate cancer. Urology, 61: 386-390, 2003.
93. Pfister, C., Chautard, D., Devonec, M., Perrin, P., Chopin, D., Rischmann, P., Bouchot, O., Beurton, D.,
Coulange, C., and Rambeaud, J. J. Immunocyt test improves the diagnostic accuracy of urinary cytology:
results of a French multicenter study. J Urol, 169: 921-924, 2003.
94. Vivo, C., Lecomte, C., Levy, F., Leroy, K., Kirova, Y., Renier, A., Kheuang, L., Piedbois, P., Chopin, D.,
and Jaurand, M. C. Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to
gamma radiation. Br J Cancer, 88: 388-395, 2003.
95. van Rhijn, B. W., Lurkin, I., Chopin, D. K., Kirkels, W. J., Thiery, J. P., van der Kwast, T. H., Radvanyi, F.,
and Zwarthoff, E. C. Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive
detection of urothelial cell carcinoma in voided urine. Clin Cancer Res, 9: 257-263, 2003.
96. Salomon, L., Levrel, O., Anastasiadis, A. G., Irani, J., De La Taille, A., Saint, F., Vordos, D., Cicco, A.,
Hoznek, A., Chopin, D., and Abbou, C. C. Prognostic significance of tumor volume after radical
prostatectomy: a multivariate analysis of pathological prognostic factors. Eur Urol, 43: 39-44, 2003.
97. Bakkar A, Wallerand H, Radvanyi F, Lahaye JB, Pissard S, Lecerf L, Kouyoumdjian JC, Abbou CC, Pairon
JC, Jaurand MC, Thiery JP, Chopin DK, Gil Diez De Medina S. FGFR3 and TP53 gene mutations define
two distinct pathways in urothelial cell carcinoma of the bladder. Cancer Research, 63: 8108-8112, 2003
Année 2004
98. Céraline J., Cruchant M.D., Erdmann E. , Erbs Ph., Kurtz J.E., Duclos B., Jacqmin D., Chopin D., and
Bergerat J.P. Constitutive activation of the androgen receptor by a point mutation in the hinge region : a new
mechanism for androgen-independent growth in prostate cancer. Int J Cancer, 108:152-157, 2004
99. Popov Z, Gil-Diez De Medina S, Ravery V, Hoznek A, Bastuji-Garin S, Le Frere-Belda MA, Abbou CC,
Chopin DK. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer. Urol Oncol,
2004, 22:00-00
100. Daher A., De Boer W.I., Le Frère Belda M.A., Kheuang L., Abbou C.C., Radvanyi F., M.C. Jaurand, Thiery
J.P., Gil Diez de Medina S., Chopin D.K. Growth, differentiation and Senescence of Normal Human
Urothelium in organ like culture. European Urology, (45) 799-805, 2004
101. Huguenin S, Vacherot F, Kheuang L, Fleury-Feith J, Jaurand MC, Bolla M, Riffaud JP, Chopin DK.
Antiproliferative effect of nitrosulindac (NCS 1102), a new nitric oxide-donating non steroidal antiinflammatory
drug (NO-NSAID), on human bladder carcinoma cell lines. Mol Cancer Ther. 3 (3):1-9, 2004
102. Huguenin S, Fleury-Feith J, Kheuang L, Jaurand MC, Bolla M, Riffaud JP, Chopin D, Vacherot F.
Nitrosulindac (NCS 1102), a new nitric oxide-donating non steroidal antiinflammatory drug (NO-SAIDS),
inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines. The Prostate, (sous
presse)
103. Makhoul B, De La Taille A, Salomon P, Sebe P, Audet JF, Ruiz L, Hoznek A, Antiphon P, Cicco A, Vordos
D, Yiou R, Chopin D, Abbou C. C. Laparoscopic radical nephrectomy for T1 renal cancer : the gold
standard A comparison of laparoscopic vs open nephrectomy. Br J Urol, (sous presse)
104. Saint F., Le Frère Belda M.A., Quintela R., Hoznek A., Patard J.J., Bellot J., Popov Z., Zafrani E.S., Abbou
C.C., D. Chopin, S. Gil Diez de Medina. Pretreatment in p53 overexpression as a prognostic marker in
superficial bladder cancer treated with Bacillus Calmette-Guérin (BCG). Eur Urol, 2004 in press
26